Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
244.21
-5.80 (-2.32%)
May 14, 2025, 10:11 AM - Market open
Labcorp Holdings Employees
Labcorp Holdings had 70,000 employees as of December 31, 2024. The number of employees increased by 3,000 or 4.48% compared to the previous year.
Employees
70,000
Change (1Y)
3,000
Growth (1Y)
4.48%
Revenue / Employee
$188,249
Profits / Employee
$10,440
Market Cap
20.44B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 70,000 | 3,000 | 4.48% |
Dec 31, 2023 | 67,000 | -13,000 | -16.25% |
Dec 31, 2022 | 80,000 | 5,000 | 6.67% |
Dec 31, 2021 | 75,000 | 2,600 | 3.59% |
Dec 31, 2020 | 72,400 | 7,400 | 11.38% |
Dec 31, 2019 | 65,000 | 4,000 | 6.56% |
Dec 31, 2018 | 61,000 | 1,000 | 1.67% |
Dec 31, 2017 | 60,000 | 8,000 | 15.38% |
Dec 31, 2016 | 52,000 | 2,000 | 4.00% |
Dec 31, 2015 | 50,000 | 2,000 | 4.17% |
Dec 31, 2014 | 48,000 | 14,000 | 41.18% |
Dec 31, 2013 | 34,000 | 0 | - |
Dec 31, 2012 | 34,000 | 3,000 | 9.68% |
Dec 31, 2011 | 31,000 | 0 | - |
Dec 31, 2010 | 31,000 | 3,000 | 10.71% |
Dec 31, 2009 | 28,000 | 0 | - |
Dec 31, 2008 | 28,000 | 2,000 | 7.69% |
Dec 31, 2007 | 26,000 | 1,000 | 4.00% |
Dec 31, 2006 | 25,000 | 1,000 | 4.17% |
Dec 31, 2005 | 24,000 | 500 | 2.13% |
Dec 31, 2004 | 23,500 | 500 | 2.17% |
Dec 31, 2003 | 23,000 | -1,000 | -4.17% |
Dec 31, 2002 | 24,000 | 4,400 | 22.45% |
Dec 31, 2001 | 19,600 | 750 | 3.98% |
Dec 31, 2000 | 18,850 | 890 | 4.96% |
Dec 31, 1999 | 17,960 | -840 | -4.47% |
Dec 31, 1998 | 18,800 | 200 | 1.08% |
Dec 31, 1997 | 18,600 | -3,400 | -15.45% |
Dec 31, 1996 | 22,000 | -2,600 | -10.57% |
Dec 31, 1995 | 24,600 | 10,600 | 75.71% |
Dec 31, 1994 | 14,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LH News
- 5 days ago - Labcorp to Webcast Its Annual Meeting of Shareholders May 15 - PRNewsWire
- 14 days ago - Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters
- 15 days ago - Labcorp Announces 2025 First Quarter Results - PRNewsWire
- 21 days ago - Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions - PRNewsWire
- 4 weeks ago - Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics - GlobeNewsWire
- 4 weeks ago - Labcorp Declares Quarterly Dividend - PRNewsWire
- 6 weeks ago - Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease - PRNewsWire